Biotech Values

[mcbio]

ABT licenses anti-CD4 mAb from Biotest AG

Perhaps I'm being unduly harsh but do you see a lot of long-term upside for another RA monoclonal antibody that's just in mid-stage testing given the existing RA monoclonal antibodies on the market, the other ones in development, and the prospect of the oral RA pills and generic RA biologics to come?